采用包含新型和重新利用药物的方案治疗的耐多药结核病患者的妊娠及分娩结局
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
作者信息
Lotia Farrukh Ismat, Lachenal Nathalie, Adenov Malik M, Ahmed Saman, Algozhin Yerkebulan, Coutisson Sylvine, Garavito Epifanio Sánchez, Hewison Catherine, Holtzman David, Huerga Helena, Janmohamed Aleeza, Khan Palwasha Y, Jacques Gamarly Leblanc, Lomtadze Nino, Melikyan Nara, Mitnick Carole D, Mussabekova Gulnaz, Osso Elna, Perea Sara, Putri Fauziah Asnely, Rashidov Mahmud, Rich Michael L, Sakhabutdinova Yekaterina, Seung Kwonjune J, Stambekova Assel, Vásquez Dante Vargas, Franke Molly F, Khan Uzma
机构信息
Interactive Research and Development Pakistan, Karachi, Pakistan.
Pharmacovigilance Unit, Médecins Sans Frontières, Geneva, Switzerland.
出版信息
Clin Infect Dis. 2024 Jan 25;78(1):144-148. doi: 10.1093/cid/ciad445.
Abstract
Among 43 pregnant women receiving multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment with bedaquiline and/or delamanid, 98% had favorable treatment outcomes. Of 31 continued pregnancies, 81% had live births with no reported malformations, and 68% of neonates had normal birth weights. Effective MDR/RR-TB treatment during pregnancy can improve maternal outcomes without harming neonates.
摘要
在43名接受含贝达喹啉和/或德拉马尼的耐多药/利福平耐药结核病（MDR/RR-TB）治疗的孕妇中，98%获得了良好的治疗结局。在31例持续妊娠中，81%分娩活婴，未报告有畸形，68%的新生儿出生体重正常。孕期有效的MDR/RR-TB治疗可改善孕产妇结局，且不损害新生儿。
相似文献
1
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.采用包含新型和重新利用药物的方案治疗的耐多药结核病患者的妊娠及分娩结局
Clin Infect Dis. 2024 Jan 25;78(1):144-148. doi: 10.1093/cid/ciad445.
2
Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.新/伴随药物治疗既往结核病对贝达喹啉和德拉马尼联合治疗耐多药和利福平结核病患者临床结局的影响。
Clin Infect Dis. 2024 Apr 10;78(4):1043-1052. doi: 10.1093/cid/ciad694.
3
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.《endTB 观察性研究方案：贝达喹啉或含德拉马尼方案治疗耐多药结核病》。
BMC Infect Dis. 2019 Aug 20;19(1):733. doi: 10.1186/s12879-019-4378-4.
4
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.在德国，将新型或第5组干预措施添加到背景治疗方案中用于治疗耐多药结核病的成本效益。
BMC Health Serv Res. 2017 Mar 8;17(1):182. doi: 10.1186/s12913-017-2118-2.
5
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial.贝达喹啉、德拉马尼或两者联合治疗利福平耐药结核病患者的 QT 影响：一项 2 期、开放标签、随机、对照试验。
Lancet Infect Dis. 2021 Jul;21(7):975-983. doi: 10.1016/S1473-3099(20)30770-2. Epub 2021 Feb 12.
6
7
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.贝达喹啉和/或德拉马尼治疗患者的文化转变。一项前瞻性多国研究。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):111-119. doi: 10.1164/rccm.202001-0135OC.
8
Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review.贝达喹啉和德拉马尼单用方案治疗耐药结核病的良好结局：一项系统评价。
Int J Mycobacteriol. 2023 Jan-Mar;12(1):1-9. doi: 10.4103/ijmy.ijmy_217_22.
9
▼Bedaquiline for multidrug-resistant tuberculosis.▼贝达喹啉用于耐多药结核病。
Drug Ther Bull. 2014 Nov;52(11):129-32. doi: 10.1136/dtb.2014.11.0291.
10
Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients.南非开普敦耐多药结核病孕妇应用新药治疗后所生孩子的结局：5 例报告。
Pediatr Infect Dis J. 2021 May 1;40(5):e191-e192. doi: 10.1097/INF.0000000000003069.
引用本文的文献
1
An Update on the Clinical Management of HIV and Tuberculosis Co-Infection in Pregnancy: TB Preventative Therapy, Long-Acting ARVs, and Bedaquiline-Based Regimens.孕期艾滋病毒与结核病合并感染的临床管理最新进展：结核病预防性治疗、长效抗逆转录病毒药物及基于贝达喹啉的治疗方案
Curr HIV/AIDS Rep. 2025 Jun 16;22(1):37. doi: 10.1007/s11904-025-00746-z.
2
Update in tuberculosis treatment: a scoping review of current practices.结核病治疗的最新进展：当前实践的范围综述
Breathe (Sheff). 2025 Mar 18;21(1):240232. doi: 10.1183/20734735.0232-2024. eCollection 2025 Jan.
3
Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.TB-PRACTECAL中耐多药结核病的妊娠结局
Clin Infect Dis. 2024 Aug 16;79(2):569-570. doi: 10.1093/cid/ciad767.
本文引用的文献
1
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.符合世卫组织标准的、更长时间的、全口服耐多药结核病方案的结果及分析意义。
Int J Tuberc Lung Dis. 2023 Jun 1;27(6):451-457. doi: 10.5588/ijtld.22.0613.
2
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB.三种操作方法在耐多药结核病结局定义中的一致性。
Int J Tuberc Lung Dis. 2023 Jan 1;27(1):34-40. doi: 10.5588/ijtld.22.0324.
3
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.贝达喹啉治疗耐多药结核病患者超过六个月的疗效。
Am J Respir Crit Care Med. 2023 Jun 1;207(11):1525-1532. doi: 10.1164/rccm.202211-2125OC.
4
Evidence for Implementation: Management of TB in HIV and Pregnancy.证据实施：艾滋病毒和妊娠中的结核病管理。
Curr HIV/AIDS Rep. 2022 Dec;19(6):455-470. doi: 10.1007/s11904-022-00641-x. Epub 2022 Oct 29.
5
Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis.耐多药结核病孕妇患者的治疗结局：系统评价和荟萃分析。
JAMA Netw Open. 2022 Jun 1;5(6):e2216527. doi: 10.1001/jamanetworkopen.2022.16527.
6
Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients.南非开普敦耐多药结核病孕妇应用新药治疗后所生孩子的结局：5 例报告。
Pediatr Infect Dis J. 2021 May 1;40(5):e191-e192. doi: 10.1097/INF.0000000000003069.
7
Treatment outcomes of pregnant women with drug-resistant tuberculosis in Uganda: A retrospective review of 18 cases.乌干达耐药结核病孕妇的治疗结果：18 例回顾性研究
Int J Infect Dis. 2021 Apr;105:230-233. doi: 10.1016/j.ijid.2021.02.032. Epub 2021 Feb 18.
8
Setting up pharmacovigilance based on available endTB Project data for bedaquiline.建立基于现有耐多药结核病项目数据的药物警戒系统。
Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1087-1094. doi: 10.5588/ijtld.20.0115.
9
Tuberculosis clinical presentation and treatment outcomes in pregnancy: a prospective cohort study.妊娠结核病的临床表现和治疗结局：一项前瞻性队列研究。
BMC Infect Dis. 2020 Sep 18;20(1):686. doi: 10.1186/s12879-020-05416-6.
10
Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa.南非接受多药/利福平耐药结核病治疗的孕妇的母婴结局。
Clin Infect Dis. 2021 Apr 8;72(7):1158-1168. doi: 10.1093/cid/ciaa189.
Zotero 插件